These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2011292)

  • 1. A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
    Stuart RA; Gow PJ; Bellamy N; Campbell J; Grigor R
    N Z Med J; 1991 Mar; 104(908):115-7. PubMed ID: 2011292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario.
    Bellamy N; Gilbert JR; Brooks PM; Emmerson BT; Campbell J
    J Rheumatol; 1988 Dec; 15(12):1841-7. PubMed ID: 3265960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of current evaluation and treatment of gout.
    Schlesinger N; Moore DF; Sun JD; Schumacher HR
    J Rheumatol; 2006 Oct; 33(10):2050-2. PubMed ID: 17014020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of opinions on the management of gout in France. A survey of 750 rheumatologists.
    Rozenberg S; Lang T; Laatar A; Koeger AC; Orcel P; Bourgerois P
    Rev Rhum Engl Ed; 1996 Apr; 63(4):255-61. PubMed ID: 8738444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
    George M; Pullman-Mooar S; Hussain F; Schumacher HR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis in New South Wales and Queensland.
    Bellamy N; Brooks PM; Emmerson BT; Gilbert JR; Campbell J; McCredie M
    Med J Aust; 1989 Nov; 151(9):531-2 535-7. PubMed ID: 2811727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to select and use urate lowering agents for hyperuricemia].
    Yamanaka H
    Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hyperuricemia and gout].
    Pöllmann G; Kullich W; Klein G
    Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum urate during bouts of acute gouty arthritis.
    Schlesinger N; Baker DG; Schumacher HR
    J Rheumatol; 1997 Nov; 24(11):2265-6. PubMed ID: 9375898
    [No Abstract]   [Full Text] [Related]  

  • 12. A survey on the management of gout in Malaysia.
    Yeap SS; Goh EM; Gun SC
    Int J Rheum Dis; 2009 Dec; 12(4):329-35. PubMed ID: 20374371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gout and hyperuricaemia--should both be treated?].
    Uhlig T
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2878-80. PubMed ID: 14600714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in the management of gout.
    Keith MP; Gilliland WR
    Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N
    Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
    Roddy E; Zhang W; Doherty M
    Ann Rheum Dis; 2007 Oct; 66(10):1311-5. PubMed ID: 17504843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.